| Tigran Martikyan, MD | |
|
325 N Kenwood St Apt B, Glendale, CA 91206-3543 | |
| (818) 433-9915 | |
| Not Available |
| Full Name | Tigran Martikyan |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 325 N Kenwood St Apt B, Glendale, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538425814 | NPI | - | NPPES |
| Entity Name | East Valley Emergency Medical Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346287430 PECOS PAC ID: 3870579691 Enrollment ID: O20050506000210 |
News Archive
A research paper published in the scientific journal Tobacco Control, "Cigarette graphic warning labels and smoking prevalence in Canada: a critical examination and reformulation of the FDA regulatory impact analysis", shows that graphic warning labels on cigarette packs led to a decrease in smoking rates in Canada of between 12% and 20% from 2000 to 2009. The authors estimate that if the same model was applied to the United States, the introduction of graphic warnings would potentially lead to a decrease of between 5.3 and 8.6 million smokers.
Requiring a second exam on a person who is considered brain dead may be unnecessary, according to a study on the impact of a second brain death exam on organ donation rates. The research is published in the December 15, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Chambers USA: America's Leading Lawyers for Business named Ropes & Gray the winner of the Award for Excellence, honoring it as the firm of the year for health care at a ceremony on May 19 in New York. The award reflects the firm's preeminence in the health care industry and is based on independent research by Chambers & Partners from 2014 – 2015, citing both client feedback and market commentary from lawyers outside of the firm.
Spectranetics Corporation today announced that it has filed a 510(k) application with the Food and Drug Administration seeking clearance for the treatment of in-stent restenosis (ISR) in the legs with its commercially available peripheral atherectomy products. ISR is caused by the re-growth of tissue within the stent, known as neointimal hyperplasia, which can lead to blockages in the affected leg artery.
The nanoelectronics research centre imec and Peira, a Belgium-based manufacturer of pharmaceutical and chemical research instruments, jointly developed an innovative slice-tilting instrument for in-vitro research on brain tissue. The new tool enables long-term studying of brain cultures through electronic stimulation and read-out, essential in getting insight into the functioning of the brain.
› Verified 1 days ago
| Entity Name | Onclick Healthcare Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467074963 PECOS PAC ID: 9830511260 Enrollment ID: O20200612000107 |
News Archive
A research paper published in the scientific journal Tobacco Control, "Cigarette graphic warning labels and smoking prevalence in Canada: a critical examination and reformulation of the FDA regulatory impact analysis", shows that graphic warning labels on cigarette packs led to a decrease in smoking rates in Canada of between 12% and 20% from 2000 to 2009. The authors estimate that if the same model was applied to the United States, the introduction of graphic warnings would potentially lead to a decrease of between 5.3 and 8.6 million smokers.
Requiring a second exam on a person who is considered brain dead may be unnecessary, according to a study on the impact of a second brain death exam on organ donation rates. The research is published in the December 15, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Chambers USA: America's Leading Lawyers for Business named Ropes & Gray the winner of the Award for Excellence, honoring it as the firm of the year for health care at a ceremony on May 19 in New York. The award reflects the firm's preeminence in the health care industry and is based on independent research by Chambers & Partners from 2014 – 2015, citing both client feedback and market commentary from lawyers outside of the firm.
Spectranetics Corporation today announced that it has filed a 510(k) application with the Food and Drug Administration seeking clearance for the treatment of in-stent restenosis (ISR) in the legs with its commercially available peripheral atherectomy products. ISR is caused by the re-growth of tissue within the stent, known as neointimal hyperplasia, which can lead to blockages in the affected leg artery.
The nanoelectronics research centre imec and Peira, a Belgium-based manufacturer of pharmaceutical and chemical research instruments, jointly developed an innovative slice-tilting instrument for in-vitro research on brain tissue. The new tool enables long-term studying of brain cultures through electronic stimulation and read-out, essential in getting insight into the functioning of the brain.
› Verified 1 days ago
| Entity Name | Gem Medical Group Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689364721 PECOS PAC ID: 3072984400 Enrollment ID: O20230124000274 |
News Archive
A research paper published in the scientific journal Tobacco Control, "Cigarette graphic warning labels and smoking prevalence in Canada: a critical examination and reformulation of the FDA regulatory impact analysis", shows that graphic warning labels on cigarette packs led to a decrease in smoking rates in Canada of between 12% and 20% from 2000 to 2009. The authors estimate that if the same model was applied to the United States, the introduction of graphic warnings would potentially lead to a decrease of between 5.3 and 8.6 million smokers.
Requiring a second exam on a person who is considered brain dead may be unnecessary, according to a study on the impact of a second brain death exam on organ donation rates. The research is published in the December 15, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Chambers USA: America's Leading Lawyers for Business named Ropes & Gray the winner of the Award for Excellence, honoring it as the firm of the year for health care at a ceremony on May 19 in New York. The award reflects the firm's preeminence in the health care industry and is based on independent research by Chambers & Partners from 2014 – 2015, citing both client feedback and market commentary from lawyers outside of the firm.
Spectranetics Corporation today announced that it has filed a 510(k) application with the Food and Drug Administration seeking clearance for the treatment of in-stent restenosis (ISR) in the legs with its commercially available peripheral atherectomy products. ISR is caused by the re-growth of tissue within the stent, known as neointimal hyperplasia, which can lead to blockages in the affected leg artery.
The nanoelectronics research centre imec and Peira, a Belgium-based manufacturer of pharmaceutical and chemical research instruments, jointly developed an innovative slice-tilting instrument for in-vitro research on brain tissue. The new tool enables long-term studying of brain cultures through electronic stimulation and read-out, essential in getting insight into the functioning of the brain.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tigran Martikyan, MD 325 N Kenwood St Apt B, Glendale, CA 91206-3543 Ph: (818) 433-9915 | Tigran Martikyan, MD 325 N Kenwood St Apt B, Glendale, CA 91206-3543 Ph: (818) 433-9915 |
News Archive
A research paper published in the scientific journal Tobacco Control, "Cigarette graphic warning labels and smoking prevalence in Canada: a critical examination and reformulation of the FDA regulatory impact analysis", shows that graphic warning labels on cigarette packs led to a decrease in smoking rates in Canada of between 12% and 20% from 2000 to 2009. The authors estimate that if the same model was applied to the United States, the introduction of graphic warnings would potentially lead to a decrease of between 5.3 and 8.6 million smokers.
Requiring a second exam on a person who is considered brain dead may be unnecessary, according to a study on the impact of a second brain death exam on organ donation rates. The research is published in the December 15, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Chambers USA: America's Leading Lawyers for Business named Ropes & Gray the winner of the Award for Excellence, honoring it as the firm of the year for health care at a ceremony on May 19 in New York. The award reflects the firm's preeminence in the health care industry and is based on independent research by Chambers & Partners from 2014 – 2015, citing both client feedback and market commentary from lawyers outside of the firm.
Spectranetics Corporation today announced that it has filed a 510(k) application with the Food and Drug Administration seeking clearance for the treatment of in-stent restenosis (ISR) in the legs with its commercially available peripheral atherectomy products. ISR is caused by the re-growth of tissue within the stent, known as neointimal hyperplasia, which can lead to blockages in the affected leg artery.
The nanoelectronics research centre imec and Peira, a Belgium-based manufacturer of pharmaceutical and chemical research instruments, jointly developed an innovative slice-tilting instrument for in-vitro research on brain tissue. The new tool enables long-term studying of brain cultures through electronic stimulation and read-out, essential in getting insight into the functioning of the brain.
› Verified 1 days ago
Dr. Anne Kuo, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3527 Ocean View Blvd, Glendale, CA 91208 Phone: 818-957-6909 Fax: 888-584-9315 | |
Allandale Yap, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 S Chevy Chase Dr Ste 230, Glendale, CA 91205 Phone: 818-500-5587 | |
Dr. Nare Stepanyan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 S Chevy Chase Dr Ste 230, Glendale, CA 91205 Phone: 818-500-5586 | |
Yervand Set Agayan, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 S Central Ave, Ste 306, Glendale, CA 91204 Phone: 818-242-5300 Fax: 818-244-5850 | |
Arsine Echighian Henry, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 444 W Glenoaks Blvd, Glendale, CA 91202 Phone: 818-552-3108 | |
Naira Sargsyan, Family Medicine Medicare: Medicare Enrolled Practice Location: 519 E Broadway, Glendale, CA 91205 Phone: 818-409-3020 Fax: 818-243-2713 | |
Dr. Antonio Zamorano, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1030 S Glendale Ave Ste 200, Glendale, CA 91205 Phone: 818-850-5667 Fax: 818-839-2303 |